Study Uncovers Driver of Endothelial Dysfunction in Sepsis-Induced ARDS
New insights reveal a key factor contributing to vascular injury and lung dysfunction in sepsis-induced ARDS.
Tag: ARDS acute respiratory distress syndrome
All
Latest
Study Uncovers Driver of Endothelial Dysfunction in Sepsis-Induced ARDS
New insights reveal a key factor contributing to vascular injury and lung dysfunction in sepsis-induced ARDS.
Read More
Ozone Therapy Could Improve Sepsis-induced Acute Lung Injury
Researchers found that medical ozone therapy can improve lung function in mice with sepsis-induced acute lung injury.
Read More
Microscopic Lung Collapses Spread Under Artificial Ventilation
A research team identifies microscopic clusters of damaged lung vesicles as the cause of massive loss of lung function.
Read More
Acetaminophen Reduces Organ Injury and ARDS in Sepsis Patients
In patients most at risk for organ damage, the drug lessened the need for assisted ventilation and showed a slight decrease in mortality.
Read More
Synthetic Surfactant Developed to Mimic Animal-Derived Infasurf
Researchers have previously attempted to develop synthetic lung surfactants, but some have been removed from the market and others have not been able to lower surface tension as well as animal-derived formulations.
Read More
COVID-Induced ARDS Linked to Heart Damage
Researchers have a new understanding of the link between this serious lung injury and the kind of inflammation that can lead to cardiovascular complications.
Read More
Immune Response Byproduct Key Factor in ARDS Severity
Researchers may have discovered a mechanical explanation for instability observed in the lungs in cases of acute respiratory distress syndrome, particularly in the aftermath of respiratory illnesses such as COVID-19 or pneumonia.
Read More
High-dose Inhaled Nitric Oxide Decreased ARDS-related Mortality Risk in Black Patients with COVID-19
High-dose inhaled nitric oxide (iNO) therapy may improve oxygenation and reduce the risk of ARDS-related mortality among critically ill Black patients with COVID-19, according to a first-of-its-kind study published in the American Journal of Respiratory and Critical Care Medicine.
Read More
RT 2024 February-March: The Digital Edition
In RT’s February-March 2024 issue, we cover mechanical ventilation strategies for treating patients with ARDS; aerosol delivery, oxygen therapy and resuscitation for neonates; and best practices for pediatric bronchoscopy.
Read More
Hispanic Patients with Respiratory Failure Five Times More Likely to Be Oversedated
Researchers say different levels of sedation may explain disparities in deaths from respiratory failure.
Read More
New Cell Therapy Reduces Mortality for COVID-19-related ARDS
An initial trial suggests invariant natural killer cell therapy improves survival.
Read More
School Teacher Survives Two Double-Lung Transplants in Three Days
An elementary school teacher from Kentucky survived two double-lung transplants after a series of respiratory infections destroyed her lungs and hospitalized her for over a year.
Read More
Scientists ID Respiratory Microbiome Signatures Tied to ARDS, HAP
Researchers say they have identified “robust” respiratory microbiome signatures associated with ARDS and HAP.
Read More
NIH Grant Awarded to Study Pharmaceutical Therapies for ARDS
UTHealth Houston researchers were awarded a four-year, $3.4 million NIH grant to investigate molecular mechanisms and therapeutic treatments for acute respiratory distress syndrome.
Read More
Pulse Oximetry, Ultrasound, and HFNO as New ARDS Standards
Experts have proposed a new definition for acute respiratory distress syndrome, reflecting recent research and advancements in diagnosis and treatment.
Read More
Obesity May Not Hinder ECMO Treatment in ARDS Patients
A National Institutes of Health-supported study suggests that adults with obesity may benefit from the use of extracorporeal membrane oxygenation when in intensive care for respiratory failure.
Read More
Therapy Derived from Skin Cells May Be Able to Treat Injured Lungs
The hope is that a drop of solution containing these nanocarriers, delivered to the lungs via the nose, could treat acute respiratory distress syndrome.
Read More
UIC Scientists Receive $13 Million to Study Lung Inflammation Mechanisms
The researchers hope the projects will lead to new avenues for treatments to help patients with conditions like COPD, pulmonary fibrosis, and acute respiratory distress syndrome.
Read More
Aerosolized mRNA Pneumonia Treatment Improved Symptoms in Preclinical Study
mRNA encoding immunomodulatory proteins IκBα-SR and SOD3 ameliorated symptoms in a bacterial pneumonia model.
Read More
Novel Peptide Suppresses ARDS-related Lung Inflammation
The C6 peptide inhibited the process that triggers uncontrolled inflammation and fluid buildup that can lead to ARDS.
Read More
Study Evaluates Inhaled Nitric Oxide for COVID-19
Researchers assessed outcomes of INOmax inhaled nitric oxide for COVID-19 patients hospitalized with mild-to-moderate ARDS.
Read More
7% of US Lung Transplants Went to Severe COVID Patients
7% of the nation’s more than 3,000 lung transplants between Aug. 1, 2020, and Sept. 30, 2021 were performed to treat severe, irreversible lung damage caused by COVID-19.
Read More
RT 2022 January-February: The Digital Edition
In RT’s January-February 2022 issue, we cover advanced practice respiratory therapists (APRTs); recent advancements in bronchoscopy; and acute respiratory distress syndrome and respiratory failure during the COVID-19 pandemic.
Read More
Higher ECMO Mortality in Second Wave COVID-19 Patients
Median length of ECMO was 14 days in first wave patients vs 20 days in second wave patients, with ECMO mortality greater in second wave patients 69% vs 32% .
Read More